SFA
DFTX

Sequoia Financial Advisors’s Definium Therapeutics DFTX Stock Holding History

Sequoia Financial Advisors’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$812K Buy
17,258
+13
+0.1% +$321 ﹤0.01% 1048
2026
Q1 		$326K Buy
17,245
+72
+0.4% +$1.22K ﹤0.01% 1524
2025
Q4 		$230K Buy
17,173
+41
+0.2% +$507 ﹤0.01% 1729
2025
Q3 		$202K Buy
17,132
+553
+3% +$5.16K ﹤0.01% 1626
2025
Q2 		$108K Hold
16,579
– – ﹤0.01% 1530
2025
Q1 		$97K Hold
16,579
– – ﹤0.01% 1325
2024
Q4 		$115K Buy
16,579
+1
+0% +$7 ﹤0.01% 1277
2024
Q3 		$94.3K Sell
16,578
-110
-0.7% -$765 ﹤0.01% 1230
2024
Q2 		$120K Sell
16,688
-1,224
-7% -$10.7K ﹤0.01% 1147
2024
Q1 		$168K Buy
+17,912
New +$102K ﹤0.01% 1076

Other funds holding DFTX

PFA
Peak Financial Advisors Denver, Colorado $242M AUM 19.63% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
MAP
Moody Aldrich Partners Marblehead, Massachusetts $557M AUM 122.79% 1-Year Est. Return
BRG
Bay Rivers Group Williamsburg, Virginia $293M AUM 48.17% 1-Year Est. Return
SCI
Stableford Capital II Scottsdale, Arizona $289M AUM 20.84% 1-Year Est. Return
CSP
Cary Street Partners Richmond, Virginia $4.58B AUM 24% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Sequoia Financial Advisors's DFTX Position: Q2 2026 in Review

Sequoia Financial Advisors increased its Definium Therapeutics (DFTX) stake by 0.08% in Q2 2026, buying an estimated $321 and bringing the position to 17,258 shares worth $812K. The position accounts for ﹤0.01% of the portfolio, ranked #1048.

Sequoia Financial Advisors first reported a position in DFTX in Q1 2024 and has held it in 10 quarters since. 17 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.

  • Sequoia Financial Advisors held 17,258 shares of Definium Therapeutics worth $812K as of Q2 2026.
  • Sequoia Financial Advisors bought 13 Definium Therapeutics shares in Q2 2026, an estimated $321.
  • Definium Therapeutics made up ﹤0.01% of Sequoia Financial Advisors's portfolio in Q2 2026, its #1048 holding.
  • Sequoia Financial Advisors first reported a position in Definium Therapeutics in Q1 2024 and has held it in 10 quarters since.
  • 17 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.

Based on Sequoia Financial Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.